Does RUCAPARIB CAMSYLATE Cause Nasopharyngitis? 121 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Nasopharyngitis have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 1.5% of all adverse event reports for RUCAPARIB CAMSYLATE.
121
Reports of Nasopharyngitis with RUCAPARIB CAMSYLATE
1.5%
of all RUCAPARIB CAMSYLATE reports
0
Deaths
14
Hospitalizations
How Dangerous Is Nasopharyngitis From RUCAPARIB CAMSYLATE?
Of the 121 reports, 14 (11.6%) required hospitalization.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for RUCAPARIB CAMSYLATE.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Nasopharyngitis Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE